The 7% rally over the past month has been outdone only by technology stocks. The last two months alone have seen Metsera Avidity Biosciences Merus, 89bio and Akera Therapeutics all bought out. The stock, which many considered dead money at best since last summer, is suddenly finding favor with investors.
Continue Reading
View Comments
Regeneron Adds Fuel to Hot Healthcare Trade. Which Stocks Could Follow it Higher?
Published 1 week ago
Oct 29, 2025 at 4:11 PM
Positive
Auto